https://www.selleckchem.com/products/art0380.html
A total of 2210 unique patients were included in this study. Women composed 66% of our total tested population. Patients of European ancestry composed 78% of the tested cohort. The percentages of American Indian/Alaskan Native and Native Hawaiian/Other Pacific Islander in the cohort receiving NGS testing were significantly different than their respective distributions in the reference cohort. Characterizing the demographics of patients receiving NGS testing for cancer predisposition and precision oncology using single nucleotide variant
Like
Comment
Share
